Riociguat

規格

625115-55-1CAS番号

641-755-1EC番号

methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamateIUPAC名

C20H19FN8O2化学式

422.4 g/mol分子量

Riociguat; 625115-55-1; Adempas; BAY 63-2521; BAY-63-2521; riociguatum; RU3FE2Y4XI; methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; CHEBI:76018; DTXSID50978109; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; METHYL N-(4,6-DIAMINO-2-(1-((2-FLUOROPHENYL)METHYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL)PYRIMIDIN-5-YL)-N-METHYLCARBAMATE; RefChem:59037; C02KX05; DTXCID901405436; Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate; Riociguat (BAY 63-2521); 1304478-72-5; C20H19FN8O2; MFCD19443708; methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate; methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methyl-carbamate; Riociguat [INN]; methyl ~{N}-[4,6-bis(azanyl)-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-~{N}-methyl-carbamate; Methyl 4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl(methyl)carbamate; UNII-RU3FE2Y4XI; Riociguate; Riociguat [USAN:INN:JAN]; Riociguat CRS; GZO; Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate; Adempas (TN); Riociguat (Standard); N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; RIOCIGUAT [JAN]; RIOCIGUAT [MI]; RIOCIGUAT [USAN]; RIOCIGUAT [VANDF]; RiociguatBAY 632521; RIOCIGUAT [USP-RS]; RIOCIGUAT [WHO-DD]; Riociguat (JAN/USAN/INN); SCHEMBL245457; GTPL5257; orb1221944; orb1300303; RIOCIGUAT [ORANGE BOOK]; CHEMBL2107834; RIOCIGUAT [EP MONOGRAPH]; SCHEMBL29357210; SCHEMBL29379983; SCHEMBL29419573; RIOCIGUAT [USP MONOGRAPH]; WXXSNCNJFUAIDG-UHFFFAOYSA-N; GLXC-15785; HMS5086M07; Riociguat (BAY 63-2521)?; ECC47872; EX-A2023; Riociguat,CAS:625115-55-1; EBC-27040; HY-14779R; Riociguat for system suitability CRS; s8135; AKOS015900718; AKOS032950011; BAY-632521; CCG-268912; CS-0584; DB08931; PB25734; Riociguat for FP system suitability CRS; NCGC00379065-02; NCGC00379065-03; NCGC00379065-04; NCGC00379065-05; AC-27647; AS-19299; HY-14779; DB-073136; NS00069317; T6968; D09572; BAY 63-2521; BAY 632521; EN300-7413126; F856915; Q2154494; BRD-K84783599-001-01-0; Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)methyl-, methyl ester; Carbamic acid, N-(4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)-N-methyl-, methyl ester; Methyl (4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)(methyl)carbamate; methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate; Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate; methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate; Riociguat Micronized別名